COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:CRI • FR0000130692

10.14 EUR
-0.02 (-0.2%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, CRI scores 3 out of 10 in our fundamental rating. CRI was compared to 16 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CRI had positive earnings in the past year.
  • CRI had a positive operating cash flow in the past year.
  • Of the past 5 years CRI 4 years were profitable.
  • In multiple years CRI reported negative operating cash flow during the last 5 years.
CRI.PA Yearly Net Income VS EBIT VS OCF VS FCFCRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • With a Return On Assets value of 0.28%, CRI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
  • With a Return On Equity value of 1.03%, CRI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
  • CRI's Return On Invested Capital of 5.14% is fine compared to the rest of the industry. CRI outperforms 62.50% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CRI is in line with the industry average of 6.41%.
  • The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.28%
ROE 1.03%
ROIC 5.14%
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
CRI.PA Yearly ROA, ROE, ROICCRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • CRI's Profit Margin of 0.37% is on the low side compared to the rest of the industry. CRI is outperformed by 68.75% of its industry peers.
  • In the last couple of years the Profit Margin of CRI has declined.
  • CRI has a Operating Margin (6.41%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
  • CRI has a Gross Margin of 28.51%. This is amonst the worse of the industry: CRI underperforms 81.25% of its industry peers.
  • In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
Industry RankSector Rank
OM 6.41%
PM (TTM) 0.37%
GM 28.51%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
CRI.PA Yearly Profit, Operating, Gross MarginsCRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CRI has been increased compared to 1 year ago.
  • The number of shares outstanding for CRI has been increased compared to 5 years ago.
  • The debt/assets ratio for CRI has been reduced compared to a year ago.
CRI.PA Yearly Shares OutstandingCRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CRI.PA Yearly Total Debt VS Total AssetsCRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.24, we must say that CRI is in the distress zone and has some risk of bankruptcy.
  • CRI's Altman-Z score of 1.24 is on the low side compared to the rest of the industry. CRI is outperformed by 68.75% of its industry peers.
  • The Debt to FCF ratio of CRI is 124.09, which is on the high side as it means it would take CRI, 124.09 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 124.09, CRI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
  • CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.38, CRI is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 124.09
Altman-Z 1.24
ROIC/WACC0.78
WACC6.57%
CRI.PA Yearly LT Debt VS Equity VS FCFCRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CRI (1.30) is worse than 87.50% of its industry peers.
  • A Quick Ratio of 0.86 indicates that CRI may have some problems paying its short term obligations.
  • CRI has a worse Quick ratio (0.86) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.86
CRI.PA Yearly Current Assets VS Current LiabilitesCRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.24%, which is quite impressive.
  • CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
  • The Revenue has been growing slightly by 6.67% in the past year.
  • The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%

3.2 Future

  • CRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.19% yearly.
  • The Revenue is expected to grow by 3.45% on average over the next years.
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRI.PA Yearly Revenue VS EstimatesCRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
CRI.PA Yearly EPS VS EstimatesCRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 78.00, which means the current valuation is very expensive for CRI.
  • Based on the Price/Earnings ratio, CRI is valued a bit more expensive than 68.75% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.92, CRI is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 13.30, the valuation of CRI can be described as correct.
  • Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of CRI to the average of the S&P500 Index (27.78), we can say CRI is valued rather cheaply.
Industry RankSector Rank
PE 78
Fwd PE 13.3
CRI.PA Price Earnings VS Forward Price EarningsCRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than 75.00% of the companies in the same industry.
  • CRI's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CRI is more expensive than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 74.23
EV/EBITDA 7.33
CRI.PA Per share dataCRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CRI's earnings are expected to grow with 32.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.4%
EPS Next 3Y32.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.27%, CRI has a reasonable but not impressive dividend return.
  • CRI's Dividend Yield is slightly below the industry average, which is at 3.06.
  • CRI's Dividend Yield is slightly below the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 1.27%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRI.PA Yearly Dividends per shareCRI.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

  • CRI pays out 118.52% of its income as dividend. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
CRI.PA Yearly Income VS Free CF VS DividendCRI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M
CRI.PA Dividend Payout.CRI.PA Dividend Payout, showing the Payout Ratio.CRI.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COMPAGNIE CHARGEURS INVEST

EPA:CRI (2/6/2026, 7:00:00 PM)

10.14

-0.02 (-0.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-05
Earnings (Next)02-11
Inst Owners4.68%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap252.38M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target11.56 (14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.27%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-43.78%
EPS NY rev (3m)-58.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.5%
Valuation
Industry RankSector Rank
PE 78
Fwd PE 13.3
P/S 0.35
P/FCF 74.23
P/OCF 10.6
P/B 0.97
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)0.13
EY1.28%
EPS(NY)0.76
Fwd EY7.52%
FCF(TTM)0.14
FCFY1.35%
OCF(TTM)0.96
OCFY9.43%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.54
Profitability
Industry RankSector Rank
ROA 0.28%
ROE 1.03%
ROCE 7.02%
ROIC 5.14%
ROICexc 6.13%
ROICexgc 13.12%
OM 6.41%
PM (TTM) 0.37%
GM 28.51%
FCFM 0.47%
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 124.09
Debt/EBITDA 4.67
Cap/Depr 66.89%
Cap/Sales 2.8%
Interest Coverage 250
Cash Conversion 30.87%
Profit Quality 125.93%
Current Ratio 1.3
Quick Ratio 0.86
Altman-Z 1.24
F-Score7
WACC6.57%
ROIC/WACC0.78
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year104.23%
EBIT Next 3Y38.23%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%

COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ

What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.


What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.


What is the profitability of CRI stock?

COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CRI stock?

The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 78 and the Price/Book (PB) ratio is 0.97.


How financially healthy is COMPAGNIE CHARGEURS INVEST?

The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.